BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35403861)

  • 1. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
    Herrmann K; Giovanella L; Santos A; Gear J; Kiratli PO; Kurth J; Denis-Bacelar AM; Hustinx R; Patt M; Wahl RL; Paez D; Giammarile F; Jadvar H; Pandit-Taskar N; Ghesani M; Kunikowska J
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2300-2309. PubMed ID: 35403861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center.
    Herrmann K; Giovanella L; Santos A; Gear J; Ozgen Kiratli P; Kurth J; Denis-Bacelar AM; Hustinx R; Patt M; Wahl RL; Paez D; Giammarile F; Jadvar H; Pandit-Taskar N; Ghesani M; Kunikowska J
    J Nucl Med; 2022 Dec; 63(12):1836-1843. PubMed ID: 35450957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic approaches in nuclear medicine: current status and future prospects.
    Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
    Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
    [No Abstract]   [Full Text] [Related]  

  • 4. An Impressive Approach in Nuclear Medicine: Theranostics.
    Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
    PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bench-to-Bedside Theranostics in Nuclear Medicine.
    Jokar N; Assadi M; Yordanova A; Ahmadzadehfar H
    Curr Pharm Des; 2020; 26(31):3804-3811. PubMed ID: 32067609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
    Duan H; Iagaru A; Aparici CM
    Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncological theranostics in nuclear medicine].
    Laschinsky C; Herrmann K; Fendler W; Nader M; Lahner H; Hadaschik B; Sandach P
    Radiologie (Heidelb); 2022 Oct; 62(10):875-884. PubMed ID: 36112174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General Concepts in Theranostics.
    Nunes RF; Zuppani RMF; Coutinho AM; Barbosa FG; Sapienza MT; Marin JFG; Buchpiguel CA
    PET Clin; 2021 Jul; 16(3):313-326. PubMed ID: 34053576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated thyroid cancer theranostics: radioiodine and beyond.
    Choudhury PS; Gupta M
    Br J Radiol; 2018 Nov; 91(1091):20180136. PubMed ID: 30260232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
    Giovanella L; Avram AM; Iakovou I; Kwak J; Lawson SA; Lulaj E; Luster M; Piccardo A; Schmidt M; Tulchinsky M; Verburg FA; Wolin E
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2514-2525. PubMed ID: 31392371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics.
    Hertz B; Watabe T; Baum RP
    Ann Nucl Med; 2022 Dec; 36(12):1007-1009. PubMed ID: 36346502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostics in Thyroid Cancer.
    Eilsberger F; Pfestroff A
    PET Clin; 2021 Jul; 16(3):375-382. PubMed ID: 34053581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SNMMI and EANM practice guideline for renal scintigraphy in adults.
    Blaufox MD; De Palma D; Taylor A; Szabo Z; Prigent A; Samal M; Li Y; Santos A; Testanera G; Tulchinsky M
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2218-2228. PubMed ID: 30167801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celebrating eighty years of radionuclide therapy and the work of Saul Hertz.
    Fahey FH; Grant FD
    J Appl Clin Med Phys; 2021 Jan; 22(1):4-10. PubMed ID: 33533204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
    Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
    J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine Symporter Targeting with
    Nagarajah J; Janssen M; Hetkamp P; Jentzen W
    J Nucl Med; 2017 Sep; 58(Suppl 2):34S-38S. PubMed ID: 28864610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radionuclide-based theranostics - a promising strategy for lung cancer.
    Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organizing and operating a one day clinic / theragnostic center.
    Papanastasiou E
    Hell J Nucl Med; 2023; 26 Suppl():16-18. PubMed ID: 37658555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine.
    Solnes LB; Werner RA; Jones KM; Sadaghiani MS; Bailey CR; Lapa C; Pomper MG; Rowe SP
    J Nucl Med; 2020 Mar; 61(3):311-318. PubMed ID: 31924727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing the Goal Posts: Prostate-specific Membrane Antigen Targeted Theranostics in Prostate Cancer.
    Emmett L
    Semin Oncol Nurs; 2020 Aug; 36(4):151052. PubMed ID: 32674976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.